ESMO Advanced Course on Metastatic EGFR-Mutant NSCLC 2016

Oncology Meeting Resources

28 Oct - 29 Oct 2016, Seoul, Korea, Republic of

ESMO Advanced Course Metastatic NSCLC Square

The ESMO Advanced Course on Metastatic EGFR-Mutant NSCLC 2016 was designed for understanding the biology and role of EGFR and TKI’s (1st, 2nd, 3rd generation) in the management of NSCLC; understanding the development of resistance to TKI’s and the available treatment options; understanding the role of T790M in the development of resistance; understanding the utility of different diagnostic methods in identifying the resistance mechanism and understanding the importance of the multidisciplinary team and particularly the pathologist and radiologists in optimising diagnosis and selection of the most appropriate treatment options

Presentations of the ESMO Advanced Course on Metastatic EGFR-Mutant NSCLC 2016 are available according to the presenters' agreement to release them. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Useful links





Format available

http://oncologypro.esmo.org/Meeting-Resourc...-2016/Targeting-Oncogenetic-Drivers-in-NSCLC

Date: 28 Oct 2016
Presenter: R. A. Stahel, CH
Resources: Presentation, Webcast
Topic: Anti-Cancer Agents & Biologic Therapy

http://oncologypro.esmo.org/Meeting-Resourc...-Benefit-from-First-Generation-TKI-vs.-Chemo

Date: 28 Oct 2016
Presenter: T. Mok, HK
Resources: Presentation, Webcast
Topic: Anti-Cancer Agents & Biologic Therapy

http://oncologypro.esmo.org/Meeting-Resourc...ion-of-2nd-Generation-TKI-in-1st-or-2nd-Line

Date: 28 Oct 2016
Presenter: S. Popat, UK
Resources: Presentation, Webcast
Topic: Anti-Cancer Agents & Biologic Therapy

http://oncologypro.esmo.org/Meeting-Resourc...2016/Mechanisms-of-1st-Generation-Resistance

Date: 28 Oct 2016
Presenter: B. C. Cho, KR
Resources: Presentation, Webcast
Topic: Anti-Cancer Agents & Biologic Therapy

http://oncologypro.esmo.org/Meeting-Resourc...Patients-with-T790M-as-Resistance-Mechanisms

Date: 28 Oct 2016
Presenter: M. Ahn, KR
Resources: Presentation, Webcast
Topic: Anti-Cancer Agents & Biologic Therapy

http://oncologypro.esmo.org/Meeting-Resourc...the-Diagnostics-Initially-and-at-Progression

Date: 28 Oct 2016
Presenter: E. Thunnissen, NL
Resources: Presentation, Webcast
Topic: Pathology/Molecular Biology

http://oncologypro.esmo.org/Meeting-Resourc...and-T790M-Mutations-Challenges-and-Solutions

Date: 28 Oct 2016
Presenter: J. C. H. Yang, TW
Resources: Presentation
Topic: Pathology/Molecular Biology

http://oncologypro.esmo.org/Meeting-Resourc...al-Outcomes-Incl.-Patient-Handling-Algorithm

Date: 28 Oct 2016
Presenter: J. Youn-Han, KR
Resources: Presentation, Webcast
Topic: Anti-Cancer Agents & Biologic Therapy

http://oncologypro.esmo.org/Meeting-Resourc...ression-After-Third-Generation-TKI-What-Next

Date: 28 Oct 2016
Presenter: Y. Ohe, JP
Resources: Presentation, Webcast
Topic: Anti-Cancer Agents & Biologic Therapy

http://oncologypro.esmo.org/Meeting-Resourc...tegy-to-Improve-Outcome-in-EGFR-Mutant-NSCLC

Date: 28 Oct 2016
Presenter: R. Soo, SG
Resources: Presentation, Webcast
Topic: Anti-Cancer Agents & Biologic Therapy